A Phase 2a Study of IV BCV in Subjects With Adenovirus Infection
NCT04706923
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
52
Enrollment
INDUSTRY
Sponsor class
Conditions
Adenovirus Infections
Cytomegalovirus Infection
Interventions
DRUG:
BCV
Sponsor
SymBio Pharmaceuticals